MICHAEL VOLK to Prognosis
This is a "connection" page, showing publications MICHAEL VOLK has written about Prognosis.
Connection Strength
0.148
-
Analytic morphomics identifies predictors of new-onset diabetes after liver transplantation. Clin Transplant. 2015 May; 29(5):458-64.
Score: 0.058
-
Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed? Gastroenterology. 2008 May; 134(5):1612-4.
Score: 0.036
-
Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia. Am J Transplant. 2018 10; 18(10):2451-2456.
Score: 0.018
-
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. J Hepatol. 2015 Mar; 62(3):617-24.
Score: 0.014
-
Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma. J Clin Gastroenterol. 2011 Sep; 45(8):727-32.
Score: 0.011
-
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. Transplant Proc. 2010 May; 42(4):1194-6.
Score: 0.010